MetaVia (MTVA) - Multiplikator Forward P/S
MetaVia Inc is developing a diversified portfolio of Alzheimer's and Parkinson's drugs while implementing cloud-based patient monitoring. On GURU.Markets, the forward P/S trajectory visualizes this potential, where the level indicates the status of the business valuation parameter. Operations in Western jurisdictions guarantee stability, shielding the company from geopolitical risks and sanctions pressure.
Ringkesan rincian data analitis metaviatx.com (MTVA)
- rega saham lan target rega konsensus:
- indikator kapitalisasi pasar:
- statistik nilai buku emiten:
- data liabilitas lan likuiditas perusahaan:
Utang marang Ekuitas MetaVia Inc|MTVA - Rasio utang jangka dawa marang ekuitas|Rasio utang jangka cendhak marang ekuitas MetaVia|MTVA - Tanggungan utang kumulatif perusahaan|Utang marang nilai buku MetaVia|MTVA - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan MetaVia|Likuiditas cepet metaviatx.com
- data bathi bisnis lan rasio investasi:
MTVA - Bathi perusahaan|Proyeksi bathi mangsa ngarep MetaVia Inc|MTVA - Kapitalisasi marang bathi|Prakiraan rega marang bathi MetaVia|MTVA - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MetaVia|MTVA - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan MetaVia|MTVA - Bathi resik saben siji saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan metaviatx.com|MTVA - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep MetaVia Inc
- indikator dodolan lan pendapatan:
Analisis umum perusahaan:MetaVia, Inc. (MTVA)
The forward P/S ratio assesses the market value of MetaVia Inc (MTVA) relative to expected revenue, allowing for the smoothing of volatility and the alignment of sales growth rates with margins. The current value of for the business's forward P/S reflects discounted market expectations, where strong investor loyalty toward ethical developments in the field of neurodegenerative diseases supports valuation stability even amidst the aggressive expansion of therapeutic programs.
Karo sapa MetaVia Inc saingan
Biogen - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NBIX|Regencell - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Axsome Corp AXSM|ACADIA Pharmaceuticals (ACAD) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan XENE|VKTX (Viking Therapeutics, Inc.) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Supernus Pharmaceuticals, Inc. (SUPN)|Rasio rega marang prakiraan pendapatan Catalyst Pharmaceuticals Inc (CPRX)|Multiplikator forward rega marang pendapatan Denali Corp DNLI|Harmony Biosciences - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake BHVN (biohavenpharma.com)|AMLX: Multiplikator forward rega marang pendapatan|TRVI: Rasio rega marang prakiraan pendapatan|PRAX: Multiplikator Forward P/S|Anavex Life Sciences Corp (AVXL) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan CeriBell, Inc.|Kapitalisasi marang prakiraan pendapatan PRTA (Prothena Corporation)|Multiplikator Forward P/S ALEC|ANNX - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Omeros - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Neurogene Therapeutics NGNE|ACIU - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan VYGR (voyagertherapeutics.com)|Neumora Therapeutics, Inc. (NMRA) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Scilex Holding (SCLX)|Rasio rega marang prakiraan pendapatan Tevogen Bio Holdings, Inc.|Multiplikator forward rega marang pendapatan Alpha Cognition Corp (ACOG)|Multiplikator Forward P/S CGTX|IKT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Cassava Sciences - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake ASRT (Assertio Holdings)|Coya - Multiplikator Forward P/S|VTGN - Multiplikator Forward P/S|OVID (ovidrx.com) - Multiplikator forward rega marang pendapatan|ABOS (acumenpharm.com) - Rasio rega marang prakiraan pendapatan|CRVO (CervoMed) - Multiplikator Forward P/S|Alterity Therapeutics Ltd (ATHE) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S CLNN|Multiplikator Forward P/S pepgen.com (PEPG)|Jupiter Neurosciences Inc - Multiplikator forward rega marang pendapatan|Rega forward marang dodolan RLMD|Annovis Bio - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Grace Therapeutics, Inc. GRCE|Firefly Neuroscience Inc (AIFF) - Rasio rega marang prakiraan pendapatan|Kapitalisasi marang prakiraan pendapatan KLTO|NRSN (NeuroSense Therapeutics Ltd) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan revivapharma.com (RVPH)|Rasio rega marang prakiraan pendapatan NeurAxis (NRXS)|Multiplikator forward rega marang pendapatan heliusmedical.com HSDT|Passage Bio - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake NEUP (Neuphoria Therapeutics, Inc.)|NERV: Multiplikator forward rega marang pendapatan|ATHA: Rasio rega marang prakiraan pendapatan|ADXN: Multiplikator Forward P/S|Alzamend Neuro (ALZN) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Cyclerion Therapeutics Inc.|Kapitalisasi marang prakiraan pendapatan PTIX (Protagenic)|Multiplikator Forward P/S KTTA|CRGT - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Avenue Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Multiplikator Forward P/S Brainstorm Cell Therapeutics Inc. BCLI|CARA - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan CHRO (Chromocell)|eliemtx.com (ELYM) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Intra-Cellular Therapies, Inc. (ITCI)|Rasio rega marang prakiraan pendapatan Longboard Pharmaceuticals, Inc.|Multiplikator forward rega marang pendapatan Marinus Pharmaceuticals Inc (MRNS)|Multiplikator Forward P/S NKGN|NRBO - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Sage Therapeutics, Inc. - Multiplikator forward rega marang pendapatan|Rasio rega marang pendapatan sing dikarepake SNPX (synaptogen.com)|Trevena - Multiplikator Forward P/S|VIGL - Multiplikator Forward P/S|WENA (Anew Medical) - Multiplikator forward rega marang pendapatan|CERE (Cerevel Corp) - Rasio rega marang prakiraan pendapatan
